INSPRA

Indication:

Psychogenic depression.

Depressive neuroses.

Masked depression.

Psychosomatic affections accompanied by anxiety and apathy.

Menopausal depressions.

Dysphoria and depression in alcoholics and drug-addicts.

Dosage & Administration:

Adults: Usually 2 tablets daily: morning and noon.
In severe cases the morning dose may be increased to 2 tablets.
Elderly patients: 1 tablet in the morning.
Maintenance dose: Usually 1 tablet in the morning. In cases of insomnia or severe restlessness additional treatment with sedative in the acute phase is recommended.

Preparation:

Each film coated tablet contains Flupentixol Dihydrochloride BP equivalent to Flupentixol 0.5 mg and Melitracen Hydrochloride INN equivalent to Melitracen 10 mg.